Latin America Blood-based Biomaker For Sports Medicine Market Size & Outlook
Latin America blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
Latin America blood-based biomaker for sports medicine market highlights
- The Latin America blood-based biomaker for sports medicine market generated a revenue of USD 29.6 million in 2023.
- The market is expected to grow at a CAGR of 6.6% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Brazil is expected to register the highest CAGR from 2024 to 2030.
Latin America data book summary
| Market revenue in 2023 | USD 29.6 million |
| Market revenue in 2030 | USD 46.4 million |
| Growth rate | 6.6% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, Latin America region accounted for 4.4% of the global blood-based biomaker for sports medicine market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 259.9 million by 2030.
Ck was the largest segment with a revenue share of 17.91% in 2023. Horizon Databook has segmented the Latin America blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing focus on sports participation is expected to drive the demand for advanced medical technologies, including blood-based biomarkers for sports medicine. In Latin America, community sports programs are expanding significantly, aiming to engage 50,000 young people across 15 countries by 2025.
As the region invests in sports development and athlete health, the market is expected to grow, reflecting a commitment to integrating cutting-edge solutions into sports medicine and improving overall athlete care. Moreover, funding for the expansion of sports companies in Latin America is rising as the popularity of sports continues to grow.
For instance, in October 2023, Fz Sports expanded its Latin American rights business following a USD 74 million investment. The parent company of 1190 Sports secured funding from prominent investors, such as 777 Partners and MEP Capital. This surge in investment is driving the development of sports medicine, with a notable increase in the adoption of advanced technologies, such as blood-based biomarkers. These biomarkers are becoming essential for early injury detection, performance monitoring, and recovery optimization.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America blood-based biomaker for sports medicine market size, by country, 2018-2030 (US$M)
Latin America Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
